InvestorsHub Logo

TenKay

03/22/17 4:16 PM

#1541 RE: Alan Brochstein #1540

Very little of the past projections and forward looking statements by Chad have panned out. Actually none of any significance. He tells me Alamo is worth $10 million for various reasons...but it all hangs on them getting approval by the state...by even then...if that was guaranteed I still question it for exactly the reason you state. If you read the law, the actual opportunity is quite limited.

But it does amuse me that he will swoop in when I post something, take exception to some aspect of it on the board and "privately"...yet not really answer a single question posed.

For example he says the the "exiting" officers have been identified in the filings. I can't find it. Not saying it isn't there...but I am missing it and he doesn't seem to have to the courtesy to point to which one ... other than to tell me it's there.

And where is Choo in all this? Every filing of late is signed by Chad...so is this leadership switch just for show?

ccsykes

03/24/17 2:42 PM

#1548 RE: Alan Brochstein #1540

Alan, the fact that you bring up GW Pharma suggests you still don't understand our business plan.

Texas has a horrible program - CBD for epilepsy only initially. The program goes live about the same time GW Pharma could have Epidiolex on the market. Their drug, if approved, would have FDA approval and insurance reimbursement, making the limited Texas program really uncompetitive. In addition, while they operate in the grey, there are lots of providers of CBD from industrial hemp grown overseas or domestically.



GW Pharma produces a single molecule compound formula. We're setting up to do precision expression of the entourage effect. We're setting up to offer personalized medicine based on the entourage effect, not single molecule compounds. It's like comparing apples to oranges Alan. My advice is do some research on the "entourage affect".

If you're not using precision cultivation methods like we've developed, you simply can not control with precision the chemical expression. It's what we learned and developed in our relationship with MIT.

If you actually made an effort to understand what we're doing on the science side, you might learn that we're on the cutting edge of cannabis research and development for pharmaceuticals.

It is our ability to "augment" the production of cannabis as stated by the DEA, which is looking for such a producer, that is driving our efforts.

It's a shame that the company was never able to generate sales into the cannabis industry. I thought that they would, but, for whatever reason, they have been slow to prove out acceptance of their technology beyond Canopy Growth.



The cannabis industry in the U.S. is under a cloud of uncertainty. Our technology costs 5X's more in CAPEX, but we offer 80% reduction in cost of goods and 50% increase in production. Simply put, cannabis growers and investors haven't embraced our methods because it requires an infrastructure investment industry players are afraid to make.

So we're simply going to keep it to ourselves and become a producer since the DEA opened the door for us to do so last August. All of this is explained in our public Deck.

ccsykes

03/27/17 1:26 PM

#1575 RE: Alan Brochstein #1540

The former CEO made it seem like the CLARUS program would be a big deal, but he failed miserably on getting it funded.



It's CLARA, and true, the project did have difficulty getting funded. So a new approach was put together. Are you aware CLARA is going through a GE mentorship program now?

http://www.genewsroom.com/press-releases/ge-announces-winners-healthycities-leadership-academy%E2%80%99s-open-innovation-challenge

Pasadena, Texas – Food Security
In collaboration with the Houston Food Bank, Harris County Public Health, Indoor Harvest Corporation, PeopleFund, the Pasadena Health Center (FQHC) and others, this proposal strives to produce and distribute local sources of produce in the north Pasadena community in Harris County. Additionally, this proposal seeks to increase consumption of these healthy foods by implementing "food prescriptions" to people in need and develop a need-based Food Scholarship Program which will provide free food at a Houston Food Bank partner agency, called a “Scholarship Pantry.”